GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Erech Finance Cahalacha Ltd (XTAE:EFNC-M) » Definitions » ROA %

Erech Finance Cahalacha (XTAE:EFNC-M) ROA % : -38.45% (As of Jun. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Erech Finance Cahalacha ROA %?

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Erech Finance Cahalacha's annualized Net Income for the quarter that ended in Jun. 2024 was ₪-8.34 Mil. Erech Finance Cahalacha's average Total Assets over the quarter that ended in Jun. 2024 was ₪21.70 Mil. Therefore, Erech Finance Cahalacha's annualized ROA % for the quarter that ended in Jun. 2024 was -38.45%.

The historical rank and industry rank for Erech Finance Cahalacha's ROA % or its related term are showing as below:

XTAE:EFNC-M' s ROA % Range Over the Past 10 Years
Min: -341.92   Med: -16.58   Max: 10.19
Current: -75.72

During the past 11 years, Erech Finance Cahalacha's highest ROA % was 10.19%. The lowest was -341.92%. And the median was -16.58%.

XTAE:EFNC-M's ROA % is ranked worse than
87.86% of 873 companies
in the Medical Devices & Instruments industry
Industry Median: -1.69 vs XTAE:EFNC-M: -75.72

Erech Finance Cahalacha ROA % Historical Data

The historical data trend for Erech Finance Cahalacha's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Erech Finance Cahalacha ROA % Chart

Erech Finance Cahalacha Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROA %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -11.09 2.00 1.15 -28.83 -54.62

Erech Finance Cahalacha Semi-Annual Data
Dec13 Dec14 Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
ROA % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.70 -51.09 -22.47 -105.78 -38.45

Competitive Comparison of Erech Finance Cahalacha's ROA %

For the Medical Devices subindustry, Erech Finance Cahalacha's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Erech Finance Cahalacha's ROA % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Erech Finance Cahalacha's ROA % distribution charts can be found below:

* The bar in red indicates where Erech Finance Cahalacha's ROA % falls into.



Erech Finance Cahalacha ROA % Calculation

Erech Finance Cahalacha's annualized ROA % for the fiscal year that ended in Dec. 2023 is calculated as:

ROA %=Net Income (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=-25.293/( (69.148+23.472)/ 2 )
=-25.293/46.31
=-54.62 %

Erech Finance Cahalacha's annualized ROA % for the quarter that ended in Jun. 2024 is calculated as:

ROA %=Net Income (Q: Jun. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Jun. 2024 ))/ count )
=-8.342/( (23.472+19.918)/ 2 )
=-8.342/21.695
=-38.45 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is two times the semi-annual (Jun. 2024) net income data. ROA % is displayed in the 30-year financial page.


Erech Finance Cahalacha  (XTAE:EFNC-M) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

ROA %(Q: Jun. 2024 )
=Net Income/Total Assets
=-8.342/21.695
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-8.342 / 0.142)*(0.142 / 21.695)
=Net Margin %*Asset Turnover
=-5874.65 %*0.0065
=-38.45 %

Note: The Net Income data used here is two times the semi-annual (Jun. 2024) net income data. The Revenue data used here is two times the semi-annual (Jun. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


Erech Finance Cahalacha ROA % Related Terms

Thank you for viewing the detailed overview of Erech Finance Cahalacha's ROA % provided by GuruFocus.com. Please click on the following links to see related term pages.


Erech Finance Cahalacha Business Description

Traded in Other Exchanges
N/A
Address
Yakov Eliav 5, Downtown, Jerusalem, ISR
Erech Finance Cahalacha Ltd, formerly Insuline Medical Ltd is a medical device company. It develops & markets technologies to the clinical effectiveness of devices & drugs for the treatment of diabetes. Its products include the InsuPatch device for insulin pump users, & the InsuPad device for injection users. The InsuPad is a company's flagship product.

Erech Finance Cahalacha Headlines

No Headlines